You are here

P&T News

December 7

Republican leaders say “step-by-step” process could take several years
Report predicts loss of $400 billion in hospital revenues as people lose coverage
Prescription device provides insulin dosing recommendations
New ovarian cancer indication joins several previous cancer approvals

December 6

Open letter expresses liberal concerns
Physicians prefer newer, more-costly drugs over generics
Second-line treatment extends survival by 5.7 months compared with platinum-pemetrexed
Treatment tops sitagliptin, exenatide, insulin glargine, and placebo in clinical trials

December 5

President urges increased enrollment as law faces GOP axe
Association offers suggestions for cutting red tape
Spending averaged nearly $10,000 per person
Post-marketing study links treatment to reduced risk of cardiovascular death
Treatment is superior to imatinib in adults with CML

December 2

Industry leaders meet at annual health care summit
Other changes sought to reduce regulatory burden
Laparoscopic morcellators spread cancer cells

Pages